Laura A. Brannelly

Field and laboratory studies of the susceptibility of the green treefrog (Hyla cinerea) to Batrachochytrium dendrobatidis infection.

Clinical trials with itraconazole as a treatment for chytrid fungal infections in amphibians.

Chytrid fungus Batrachochytrium dendrobatidis has nonamphibian hosts and releases chemicals that cause pathology in the absence of infection.

Fitness consequences of infection by Batrachochytrium dendrobatidis in northern leopard frogs (Lithobates pipiens).

Batrachochytrium dendrobatidis in natural and farmed Louisiana crayfish populations: prevalence and implications.

Susceptibility of amphibians to chytridiomycosis is associated with MHC class II conformation.

Treatment trial of clinically ill corroboree frogs with chytridiomycosis with two triazole antifungals and electrolyte therapy.

Dynamics of Chytridiomycosis during the Breeding Season in an Australian Alpine Amphibian.

Amphibians with infectious disease increase their reproductive effort: evidence for the terminal investment hypothesis.

Effects of chytridiomycosis on hematopoietic tissue in the spleen, kidney and bone marrow in three diverse amphibian species.

Reservoir-host amplification of disease impact in an endangered amphibian.

Characterization of MHC class IA in the endangered southern corroboree frog.

Epidermal cell death in frogs with chytridiomycosis.

The efficacy and pharmacokinetics of terbinafine against the frog-killing fungus (Batrachochytrium dendrobatidis).